Aviva PLC Decreases Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Aviva PLC decreased its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 31.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 11,509 shares of the company's stock after selling 5,348 shares during the quarter. Aviva PLC's holdings in Doximity were worth $614,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in DOCS. Wells Fargo & Company MN boosted its stake in shares of Doximity by 3.3% during the fourth quarter. Wells Fargo & Company MN now owns 368,941 shares of the company's stock worth $19,698,000 after buying an additional 11,811 shares during the period. ExodusPoint Capital Management LP purchased a new position in shares of Doximity in the 4th quarter valued at approximately $2,119,000. Bryce Point Capital LLC acquired a new position in shares of Doximity in the fourth quarter valued at approximately $591,000. Huntington National Bank raised its stake in shares of Doximity by 1,440.8% during the fourth quarter. Huntington National Bank now owns 1,094 shares of the company's stock worth $58,000 after purchasing an additional 1,023 shares during the last quarter. Finally, Trexquant Investment LP purchased a new position in Doximity in the 4th quarter valued at $9,791,000. Institutional investors and hedge funds own 87.19% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on DOCS shares. Needham & Company LLC raised their target price on shares of Doximity from $65.00 to $82.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Leerink Partners raised Doximity from a "market perform" rating to an "outperform" rating and lifted their price objective for the company from $60.00 to $90.00 in a report on Friday, February 7th. Piper Sandler raised Doximity from a "neutral" rating to an "overweight" rating and increased their target price for the stock from $31.00 to $78.00 in a research note on Friday, February 7th. Wells Fargo & Company restated an "equal weight" rating on shares of Doximity in a research note on Friday, February 7th. Finally, Bank of America increased their price objective on Doximity from $54.00 to $57.00 and gave the stock a "neutral" rating in a research report on Monday, January 6th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $65.00.

Doximity Price Performance

NASDAQ:DOCS traded down $0.14 during mid-day trading on Wednesday, reaching $53.09. The company's stock had a trading volume of 394,101 shares, compared to its average volume of 1,974,747. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21. The company's fifty day simple moving average is $64.53 and its two-hundred day simple moving average is $55.63. The stock has a market cap of $9.91 billion, a P/E ratio of 53.10, a P/E/G ratio of 4.10 and a beta of 1.41.

Insider Buying and Selling

In other news, Director Timothy S. Cabral sold 20,000 shares of the company's stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. 37.40% of the stock is currently owned by company insiders.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.